文献リスト

1）Sano K, Ichikawa T, Araki T, et al. Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging. Radiology. 2011; 261: 834-44

2）Hwang J, Kim SH, Lee JY, et al. Small (<=2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT. Br J Radiol. 2012 ; 85: e314-22

3）Park MJ, Kim YK, Rhim H, et al. Small hepatocellular carcinomas: Improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns. Radio-logy. 2012 Jul 27. [Epub ahead of print]

4）Kim JE, Kim SH, Rhim H, et al. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characte-rization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging. AJR Am J Roentgenol. 2011; 196: W758-65

5）Le Moigne F, Durieux M, Rode A, et al. Impact of diffusion-weighted MR imaging on the characteri-zation of small hepatocellular carcinoma in the cirrhotic liver. Magn Reson Imaging. 2012; 30: 656-65

6）Rimola J, Forner A, Bruix J, et al. Non-invasive diagnosis of hepatocellular carcinoma ≦2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI. J Hepatol. 2012; 56: 1317-23

7）Serste´ T, Barrau V, Degos F, et al. Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: Role of biopsy. Hepatology. 2012; 55: 800-6

8）Nonami T, Harada A, Takagi H, et al. Hepatic resection for hepatocellular carcinoma. Am J Surg. 1997; 173: 288-91

9）Inayoshi J, Ichida T, Asakura H, et al. Gross appearance of hepatocellular carcinoma reflects E-cadherin expression and risk of early re-currence after surgical treatment. J Gastroenterol Hepatol. 2003; 18: 673-7

10）Choi GH, Han DH, Lee WJ,et al. Outcome after curative resection for a huge (>or=10 cm) hepatocellular carcinoma and prognostic significance of gross tumor classification. Am J Surg. 2009; 198: 693-701

11）Shirabe K, Aishima S, Maehara Y, et al. Prognostic importance of the gross classification of hepatocellular carcinoma in living donor-related liver transplantation. Br J Surg. 2011; 98: 261-7

12）Ariizumi S, Kitagawa K, Yamamoto M et al. A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma. J Hepatobiliary Pancreat Sci. 2011; 18: 575-85

13）Chou CT, Chen RC, Chen YL, et al. Prediction of microvascular invasion of hepatocellular carcinoma by pre-operative CT imaging. Br J Radiol. 2012; 85: 778-83

14）An C, Park MS, Kim KW, et al. Prediction of the histopathological grade of hepatocellular carcinoma using qualitative diffusion-weighted, dynamic, and hepatobiliary phase MRI. Eur Radiol. 2012; 22: 1701-8

15）Saito K, Moriyasu F, Tokuuye K,et al. Histological grade of differentiation of hepatocellular carcinoma: comparison of the efficacy of diffusion-weighted MRI with T2-weighted imaging and angiography-assisted CT. J Med Imaging Radiat Oncol. 2012; 56: 261-9

16）Haradome H, Grazioli L, Colagrande S, et al. T2-weighted and diffusion-weighted MRI for discriminating benign from malignant focal liver lesions: diagnostic abilities of single versus combined interpretations. J Magn Reson Imaging. 2012; 35: 1388-96

17）Kitao A, Matsui O, Nakanuma Y, et al. The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging. Eur Radiol. 2011; 21: 2056-66

18）Kobayashi S, Matsui O, Kitao A, et al. Relationship between signal intensity on hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced MR imaging and prognosis of borderline lesions of hepatocellular carcinoma. Eur J Radiol. 2012 Jun 28. [Epub ahead of print]

19）Kobayashi S, Matsui O, Kitao A, et al. Intranodular signal intensity analysis of hypo-vascular high-risk borderline lesions of HCC that illustrate multi-step hepatocarcinogenesis within the nodule on Gd-EOB-DTPA-enhanced MRI. Eur J Radiol. 2012 Aug 9. [Epub ahead of print]

20）Kumada T, Toyoda H,Ishikawa T, et al. Evolution of hypointense hepatocellular nodules observed only in the hepatobiliary phase of gadoxetate disodium-enhanced MRI. AJR Am J Roentgenol. 2011; 197: 58-63

21）Kim YK, Lee WJ, Choi D, et al. Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: Potential of DW imaging in predicting progression to hypervascular HCC. Radiology. 2012 Aug 13. [Epub ahead of print]

22）Akai H, Matsuda Ohtomo K, et al. Fate of hypointense lesions on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Eur J Radiol. 2012 Jan 24. [Epub ahead of print]

23）Baek CK, Choi JY, Kim KW, et al. Hepatocellular carcinoma in patients with chronic liver disease: a comparison of gadoxetic acid-enhanced MRI and multiphasic MDCT. Clin Radiol. 2012; 67: 148-56

24）Haradome H, Grazioli L, Colagrande S, et al. Additional value of gadoxetic acid-DTPA-en-hanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carci-noma: comparison with dynamic triple-phase multidetector CT. J Magn Reson Imaging. 2011; 34: 69-78

25）Onishi H, Kim T, Murakami T, et al. Hyper-vascular hepatocellular carcinomas: detection with gadoxetate disodium-enhanced MR imaging and multiphasic multidetector CT. Eur Radiol. 2012; 22(4): 845-54

26）Akai H, Kiryu S, Ohtomo K, et al. Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT. Eur J Radiol. 2011; 80: 310-5

27）Inoue T, Kudo M, Murakami T, et al. Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT. J Gastroenterol. 2012; 47: 1036-47

28）Kim PN, Choi D, Lim HK, et al. Planning ultrasound for percutaneous radiofrequency ablation to treat small (≤ 3 cm) hepatocellular carcinomas detected on computed tomography or magnetic resonance imaging: a multicenter prospective study to assess factors affecting ultrasound visibility. J Vasc Interv Radiol. 2012; 23: 627-34

29）Kim JE, Kim YS, Cho SK, et al. Outcomes of patients with hepatocellular carcinoma referred for percutaneous radiofrequency ablation at a tertiary center: analysis focused on the feasibility with the use of ultrasonography guidance. Eur J Radiol. 2011; 79: e80-4

30）Lee MW, Rhim H, Lim HK, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography. AJR Am J Roentgenol. 2012; 198: 1438-44

31）Liu FY, Yu XL, Zhang XH, et al. Microwave ablation assisted by a real-time virtual navigation system for hepatocellular carcinoma undetectable by conventional ultrasonography. Eur J Radiol. 2012; 81: 1455-9

32）Masuzaki R, Shiina S, Koike K, et al. Utility of contrast-enhanced ultrasonography with Sona-zoid in radiofrequency ablation for hepatocellular carcinoma. J Gastroenterol Hepatol. 2011; 26: 759-64

33）Minami Y, Kudo M. Review of dynamic contrast-enhanced ultrasound guidance in ablation therapy for hepatocellular carcinoma. World J Gastroenterol. 2011; 17: 4952-9

34）Frieser M, Kiesel J, Strobel D, et al. Efficacy of contrast-enhanced US versus CT or MRI for the therapeutic control of percutaneous radio-frequency ablation in the case of hepatic mali-gnancies. Ultraschall Med. 2011; 32: 148-53

35）Tokunaga S, Koda M, Yamashita E, et al. Assessment of ablative margin by MRI with ferucarbotran in radiofrequency ablation for liver cancer: comparison with enhanced CT. Br J Radiol. 2012; 85: 745-52

36）Koda M, Tokunaga S, Kakite S, et al. Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma. Eur J Radiol. 2012; 81: 2730-6

37）Lu TL, Becce F, Schmidt S, et al. Assessment of liver tumor response by high-field (3T) MRI after radiofrequency ablation: Short- and mid-term evolution of diffusion parameters within the ablation zone. Eur J Radiol. 2012; 81(9): e944-50

38）Sugimoto K, Moriyasu Imai Y, et al. Assessment of arterial hypervascularity of hepatocellular carcinoma: comparison of contrast-enhanced US and gadoxetate disodium-enhanced MR imaging. Eur Radiol. 2012; 22: 1205-13

39）Martie A, Sporea I, Chisevescu D, et al. Contrast enhanced ultrasound for the characterization of hepatocellular carcinoma. Med Ultrason. 2011; 13: 108-13

40）Sporea I, Badea R, Voiculescu M, et al. Contrast enhanced ultrasound for the evaluation of focal liver lesions in daily practice. A multicentre study. Med Ultrason. 2012; 14: 95-100

41）Giorgio A, Calisti G, Giorgio V, et al. Characte-rization of dysplastic nodules, early hepato-cellular carcinoma and progressed hepatocellular carcinoma in cirrhosis with contrast-enhanced ultrasound. Anticancer Res. 2011; 31: 3977-82

42）Tanaka H, Iijima H, Nishiguchi S, et al. Cost-effectiveness analysis on the surveillance for hepatocellular carcinoma in liver cirrhosis patients using contrast-enhanced ultra-sonography. Hepatol Res. 2012; 42: 376-84

43）Arita J, Takahashi M, Kokudo N, et al. Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma. Ann Surg. 2011; 254: 992-9

44）Mitsunori Y, Tanaka S, Arii S, et al. Contrast-enhanced intraoperative ultrasound for hepatocellular carcinoma: high sensitivity of diagnosis and therapeutic impact. J Hepatobiliary Pancreat Sci. 2012 Mar 8. [Epub ahead of print]

45）Arita J, Hasegawa K, Kokudo N, et al. Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma. AJR Am J Roentgenol. 2011; 196: 1314-21

46）Pei X, Liu L, Cai M, et al. Contrast-enhanced ultrasonography of hepatocellular carcino-ma:correlation between quantitative parameters and histological grading. Br J Radiol. 2012; 85: e740-7

47）Pei XQ, Liu LZ, Chen MS, et al.Contrast-enhanced ultrasonography of hepatocellular carcinoma: correlation between quantitative parameters and arteries in neoangiogenesis or sinusoidal capillarization. Eur J Radiol. 2012; 81: e182-8

48）Motosugi U, Ichikawa T, Araki T, et al. Liver stiffness measured by magnetic resonance elastography as a risk factor for hepatocellular carcinoma: a preliminary case-control study. Eur Radiol. 2012 Jul 20. [Epub ahead of print]

49）Jung KS, Kim SU, Han KH, et al. Prediction of recurrence after curative resection of hepato-cellular carcinoma using liver stiffness measure-ment (FibroScan(®)). Ann Surg Oncol. 2012 Jul 3. [Epub ahead of print]

50）Harada N, Shirabe K, Maehara Y, et al. Acoustic radiation force impulse imaging predicts postoperative ascites resulting from curative hepatic resection for hepatocellular carcinoma. Surgery. 2012; 151: 837-43

51）Kim HY, Choi JY, Jung ES, et al. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class a cirrhosis. Liver Transpl. 2012; 18: 850-7

52）Higaki A, Tamada Ito K, et al. Potential clinical factors affecting hepatobiliary enhancement at Gd-EOB-DTPA-enhanced MR imaging. Magn Reson Imaging. 2012; 30: 689-93

53）Kim AY, Kim YK, Lee WJ, et al. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis. Acta Radiol. 2012 Jul 30. [Epub ahead of print]

54）Lee JE, Jang JY, Choi DL, et al. Diagnostic value for extrahepatic metastases of hepatocellular carcinoma in positron emission tomography/computed tomography scan. World J Gastro-enterol. 2012; 18(23): 2979-87

55）Jin YJ, Lee HC, Lee D, et al. Role of the routine use of chest computed tomography and bone scan in staging workup of hepatocellular carcinoma. J Hepatol. 2012 ;56: 1324-9

56）Trinchet JC, Chaffaut C, Chevret S, et al. Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicities. Hepatology. 2011; 54: 1987-97

57）Kim YK, Lee MW, Lim HK, et al. Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≤ 1.5 cm in diameter). Invest Radiol. 2012; 47(3): 159-66

58）Kim A, Lee CH, Park CM, et al. Gadoxetic acid-enhanced 3.0T MRI for the evaluation of hepatic metastasis from colorectal cancer: Metastasis is not always seen as a “defect” on the hepato-biliary phase. Eur J Radiol. 2012 Aug 22. [Epub ahead of print]

59）Lee MH, Kim SH, Rhim H, et al. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease. AJR Am J Roentgenol. 2011; 197: W868-75

60）Grazioli L, Bondioni MP, Colagrande S, et al. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology. 2012; 262(2): 520-9

61）Lee CH, Kim KA, Park CM, et al. Using low tube voltage (80kVp) quadruple phase liver CT for the detection of hepatocellular carcinoma: two-year experience and comparison with Gd-EOB-DTPA enhanced liver MRI. Eur J Radiol. 2012; 81: e605-11

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp